Virtus ETF Advisers’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-25,634
| Closed | -$68K | – | 450 |
|
|
2022
Q1 | $68K | Sell |
25,634
-1,516
| -6% | -$4.02K | 0.03% | 354 |
|
|
2021
Q4 | $118K | Sell |
27,150
-2,208
| -8% | -$9.6K | 0.04% | 371 |
|
|
2021
Q3 | $149K | Sell |
29,358
-1,538
| -5% | -$7.81K | 0.07% | 344 |
|
|
2021
Q2 | $196K | Sell |
30,896
-7,125
| -19% | -$45.2K | 0.08% | 357 |
|
|
2021
Q1 | $294K | Buy |
38,021
+678
| +2% | +$5.24K | 0.12% | 244 |
|
|
2020
Q4 | $245K | Sell |
37,343
-1,378
| -4% | -$9.04K | 0.1% | 317 |
|
|
2020
Q3 | $257K | Sell |
38,721
-5,285
| -12% | -$35.1K | 0.13% | 255 |
|
|
2020
Q2 | $367K | Sell |
44,006
-6,220
| -12% | -$51.9K | 0.17% | 242 |
|
|
2020
Q1 | $385K | Sell |
50,226
-7,311
| -13% | -$56K | 0.16% | 201 |
|
|
2019
Q4 | $478K | Buy |
57,537
+33,236
| +137% | +$276K | 0.08% | 208 |
|
|
2019
Q3 | $179K | Sell |
24,301
-1,353
| -5% | -$9.97K | 0.04% | 266 |
|
|
2019
Q2 | $288K | Buy |
25,654
+7,569
| +42% | +$85K | 0.06% | 233 |
|
|
2019
Q1 | $194K | Sell |
18,085
-2,330
| -11% | -$25K | 0.41% | 91 |
|
|
2018
Q4 | $308K | Buy |
20,415
+1,565
| +8% | +$23.6K | 0.05% | 103 |
|
|
2018
Q3 | $349K | Sell |
18,850
-13,484
| -42% | -$250K | 0.04% | 176 |
|
|
2018
Q2 | $739K | Sell |
32,334
-2,542
| -7% | -$58.1K | 0.65% | 77 |
|
|
2018
Q1 | $992K | Buy |
34,876
+18,817
| +117% | +$535K | 0.86% | 43 |
|
|
2017
Q4 | $339K | Sell |
16,059
-8,018
| -33% | -$169K | 0.43% | 103 |
|
|
2017
Q3 | $437K | Buy |
24,077
+2,202
| +10% | +$40K | 0.06% | 101 |
|
|
2017
Q2 | $339K | Buy |
+21,875
| New | +$339K | 0.05% | 92 |
|